Standardized workflows to improve consistency within the clinical lab

11 Nov 2021

The global in vitro diagnostics (IVD) market is expected to grow at a compound annual growth rate (CAGR) of 5% from 2020 to 2027. As the IVD market continues to expand, so does the prevalence of debilitating chronic and infectious diseases.

An increasingly aging population has heightened the need for highly accurate and standardized diagnostic tools to help better guide clinical decisions, optimize healthcare outcomes, and accelerate clinical laboratory processes.

Featuring exclusive interviews with a team of diagnostic experts, this eBook presents a range of state-of-the-art technologies and techniques designed to streamline and simplify slide staining and analysis. It explores why many clinical labs are now choosing to ‘go digital' in a bid to replace and upgrade current manual, labor-intensive processes and demonstrates how to effectively standardize workflows to improve consistency within the clinical lab setting.

CellaVision® DM1200

Bruker Biomedical Systems (formerly ELITechGroup)

Designed for the Mid Volume Lab - the CellaVision® DM1200 fills one of the remaining automation gaps in routine hematology testing. Designed to automate and simplify the process of performing blood and body fluid differentials, the system leverages high-speed robotics and digital imaging to automatically locate and capture high-quality images of cells. Download The Hematology Workflow White Paper When implemented together with supporting applications and software, the DM1200 becomes the eng

(0)

Links

Tags